212 related articles for article (PubMed ID: 27324804)
1. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism.
Mäkinen E; Joutsa J; Johansson J; Mäki M; Seppänen M; Kaasinen V
J Neural Transm (Vienna); 2016 Nov; 123(11):1309-1318. PubMed ID: 27324804
[TBL] [Abstract][Full Text] [Related]
2. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
3. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
Koch W; Radau PE; Hamann C; Tatsch K
J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
[TBL] [Abstract][Full Text] [Related]
4. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
5. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
[TBL] [Abstract][Full Text] [Related]
6. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
[TBL] [Abstract][Full Text] [Related]
7. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.
Apostolova I; Taleb DS; Lipp A; Galazky I; Kupitz D; Lange C; Makowski MR; Brenner W; Amthauer H; Plotkin M; Buchert R
Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics.
Allali G; Garibotto V; Mainta IC; Nicastro N; Assal F
J Neurol; 2018 Oct; 265(10):2434-2441. PubMed ID: 30155736
[TBL] [Abstract][Full Text] [Related]
9. Validation of an automated morphological MRI-based (123)I-FP-CIT SPECT evaluation method.
Perlaki G; Szekeres S; Orsi G; Papp L; Suha B; Nagy SA; Doczi T; Janszky J; Zambo K; Kovacs N
Parkinsonism Relat Disord; 2016 Aug; 29():24-9. PubMed ID: 27290659
[TBL] [Abstract][Full Text] [Related]
10. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
11. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
12. [Interobserver agreement in the visual and semi-quantitative analysis of the 123I-FP-CIT SPECT images in the diagnosis of Parkinsonian syndrome].
Suárez-Piñera M; Prat ML; Mestre-Fusco A; Fuertes J; Mojal S; Balaguer E
Rev Esp Med Nucl; 2011; 30(4):229-35. PubMed ID: 21524823
[TBL] [Abstract][Full Text] [Related]
13. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
[TBL] [Abstract][Full Text] [Related]
14. Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
Buchert R; Hutton C; Lange C; Hoppe P; Makowski M; Bamousa T; Platsch G; Brenner W; Declerck J
Nucl Med Commun; 2016 May; 37(5):509-18. PubMed ID: 26703759
[TBL] [Abstract][Full Text] [Related]
15. Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.
Söderlund TA; Dickson JC; Prvulovich E; Ben-Haim S; Kemp P; Booij J; Nobili F; Thomsen G; Sabri O; Koulibaly PM; Akdemir OU; Pagani M; van Laere K; Asenbaum-Nan S; George J; Sera T; Tatsch K; Bomanji J
J Nucl Med; 2013 May; 54(5):714-22. PubMed ID: 23492885
[TBL] [Abstract][Full Text] [Related]
16. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT.
Mäkinen E; Joutsa J; Jaakkola E; Noponen T; Johansson J; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
J Neurol; 2019 Apr; 266(4):826-834. PubMed ID: 30687897
[TBL] [Abstract][Full Text] [Related]
17. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.
Albert NL; Unterrainer M; Diemling M; Xiong G; Bartenstein P; Koch W; Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu LÖ; Kluge A; Ziebell M; Darcourt J; Nobili F; Pagani M; Sabri O; Hesse S; Borght TV; Van Laere K; Tatsch K; la Fougère C
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1315-22. PubMed ID: 26780619
[TBL] [Abstract][Full Text] [Related]
18. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
Hauser RA; Grosset DG
J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
[TBL] [Abstract][Full Text] [Related]
19. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
[TBL] [Abstract][Full Text] [Related]
20. No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome.
Schiebler T; Apostolova I; Mathies FL; Lange C; Klutmann S; Buchert R
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3302-3312. PubMed ID: 37328621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
